KALA BIO, INC. Prepaid Expense and Other Assets, Current
KALA BIO, INC. (KALA) had Prepaid Expense and Other Assets, Current of $3.35 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-19
- 2026-06-30: Prepaid Expense and Other Assets, Current $3.35M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $3.55M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.93M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.18M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.35M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $3.55M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.93M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $3.18M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $1.72M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $3.50M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.62M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $2.08M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.66M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.61M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.98M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.84M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.11M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $2.35M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $7.85M 10-K · filed 2024-03-29 | $7.66M 10-K · filed 2023-03-03 |
| 2022-09-30 | $22.58M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.14M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.54M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.20M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $4.25M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.18M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.63M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $3.01M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $4.04M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.47M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.73M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.82M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.20M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $930.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.04M 10-K · filed 2020-02-12 | |
| 2018-09-30 | $4.57M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $731.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $889.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $648.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $886.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.54M 10-Q · filed 2017-08-31 | |
| 2016-12-31 | $154.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |